期刊
SEMINARS IN IMMUNOPATHOLOGY
卷 39, 期 3, 页码 283-294出版社
SPRINGER HEIDELBERG
DOI: 10.1007/s00281-016-0615-8
关键词
B-cell; Bregs; Alzheimer's disease; Neurodegeneration
资金
- Intramural Program of the National Institute on Aging, National Institutes of Health, USA
- Russian Science Foundation, Center for Brain Neurobiology and Neurogenetics, Russia [14-15-00077]
Our understanding of B cells as merely antibody producers is slowly changing. Alone or in concert with antibody, they control outcomes of seemingly different diseases such as cancer, rheumatoid arthritis, diabetes, and multiple sclerosis. While their role in activation of effector immune cells is beneficial in cancer but bad in autoimmune diseases, their immunosuppressive and regulatory subsets (Bregs) inhibit autoimmune and anticancer responses. These pathogenic and suppressive functions are not static and appear to be regulated by the nature and strength of inflammation. Although aging increases inflammation and changes the composition and function of B cells, surprisingly, little is known whether the change affects aging-associated neurodegenerative disease, such as Alzheimer's disease (AD). Here, by analyzing B cells in cancer and autoimmune and neuroinflammatory diseases, we elucidate their potential importance in AD and other aging-associated neuroinflammatory diseases.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据